Recent changes
- Oct 7, 2026Oct 7, 2026IPO an undisclosed amount SEC
- Oct 7, 2026Oct 7, 2026Retension Pharmaceuticals Amends S-1 Again Pulse story
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Oct 7, 2026 | ipo | — | — | SEC |
Latest Pulse
- Oct 8, 2026The IPO Pipeline Is Full, Only One Deal Actually PricedPulse tracked five separate IPO-pipeline moves this week -- new S-1 filings, a direct listing, an amendment, and one SPAC pricing -- and only one of the five actually priced and began trading, the gap a raw filing count misses.→
- Oct 7, 2026Retension Pharmaceuticals Amends S-1 AgainRetension Pharmaceuticals filed a second S-1/A amendment on Oct. 7, two days after its first amendment, continuing to move its IPO registration through SEC review since Pulse first covered its original filing in September.→
- Sep 22, 2026Why Some Fall IPOs Are Filing While Others Are PricingThis fall's IPO pipeline is splitting between companies actually pricing and trading -- newcleo, Electra Therapeutics -- and a growing backlog of filed-but-not-priced names including Nscale and Wella, some sitting for weeks without terms.→
- Sep 21, 2026The Fall 2026 IPO Pipeline Just Got More CrowdedAnthropic's IPO slid a second time to November as ADARx priced at a $1.74 billion target and two more biotechs filed to go public, showing this fall's IPO pipeline growing in volume even as its biggest name keeps slipping.→
- Sep 21, 2026TRex Bio, Retension File S-1s For Nasdaq IPOsTRex Bio and Retension Pharmaceuticals both filed S-1 registration statements for Nasdaq IPOs on the same day, joining a fall biotech listing wave with Eli Lilly backing TRex's autoimmune-disease pipeline.→
Coverage Timeline
newest firstAll Coverage
Related Companies
Sources & methodologyshow
Where these figures come from
- SECprimary source1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.